| http://www.w3.org/ns/prov#value | - The Intercept Blood Systems for both platelets and plasma are already marketed in Europe and other markets, and Cerus is currently in discussions with FDA to determine the requirements for approval for the TTP indication in the U.S. An Intercept red blood cell system is currently in clinical development.
|
